HK1184440A1 - 製備海鞘素化合物及中間體的合成方法 - Google Patents

製備海鞘素化合物及中間體的合成方法

Info

Publication number
HK1184440A1
HK1184440A1 HK13111041.1A HK13111041A HK1184440A1 HK 1184440 A1 HK1184440 A1 HK 1184440A1 HK 13111041 A HK13111041 A HK 13111041A HK 1184440 A1 HK1184440 A1 HK 1184440A1
Authority
HK
Hong Kong
Prior art keywords
intermediates
manufacture
synthetic process
ecteinascidin compounds
ecteinascidin
Prior art date
Application number
HK13111041.1A
Other languages
English (en)
Inventor
Lpez M Jess Martn
Solloso Andrs Francesch
Marchante Mara Del Carmen Cuevas
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of HK1184440A1 publication Critical patent/HK1184440A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK13111041.1A 2010-05-25 2013-09-27 製備海鞘素化合物及中間體的合成方法 HK1184440A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382142 2010-05-25
PCT/EP2011/058466 WO2011147828A1 (en) 2010-05-25 2011-05-24 Synthetic process for the manufacture of ecteinascidin compounds

Publications (1)

Publication Number Publication Date
HK1184440A1 true HK1184440A1 (zh) 2014-01-24

Family

ID=44119227

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13111041.1A HK1184440A1 (zh) 2010-05-25 2013-09-27 製備海鞘素化合物及中間體的合成方法

Country Status (10)

Country Link
US (1) US9428524B2 (zh)
EP (1) EP2576569B1 (zh)
JP (1) JP6037337B2 (zh)
CN (2) CN103038240A (zh)
AU (1) AU2011257277B2 (zh)
CA (1) CA2800097C (zh)
ES (1) ES2534331T3 (zh)
HK (1) HK1184440A1 (zh)
IL (1) IL223220A (zh)
WO (1) WO2011147828A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104974056B (zh) * 2015-07-20 2017-01-11 上海皓元生物医药科技有限公司 一种用于制备曲贝替定的高纯度中间体的手性拆分方法
CN107522698B (zh) * 2016-06-20 2021-12-28 浙江海正药业股份有限公司 一种曲贝替定的制备方法及其中间体
JOP20190254A1 (ar) * 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN109912629B (zh) * 2017-12-13 2021-12-24 浙江中科创越药业有限公司 天然产物Trabectedin的制备
JPWO2019176732A1 (ja) * 2018-03-16 2021-03-25 国立大学法人東京農工大学 テトラヒドロイソキノリン環含有化合物の製造方法
CN111518110B (zh) * 2019-02-01 2023-11-03 博瑞生物医药（苏州）股份有限公司 一种海鞘素化合物及其中间体的制备方法
US20220315605A1 (en) * 2019-06-27 2022-10-06 Msn Laboratories Private Limited, R&D Center IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
CA3158733A1 (en) * 2019-11-21 2021-05-27 Pilar Calvo Methods of treating small cell lung cancer with lurbinectedin formulations
MA56827B2 (fr) * 2019-11-21 2023-09-27 Pharma Mar Sa Procédés de traitement du cancer du poumon à petites cellules avec des formulations de lurbinectédine
WO2021218896A1 (zh) * 2020-04-26 2021-11-04 江苏恒瑞医药股份有限公司 海鞘素类衍生物及其制备方法与医药用途
WO2022186221A1 (ja) * 2021-03-03 2022-09-09 国立大学法人東京大学 マクロ環含有新規テトラヒドロイソキノリンアルカロイド化合物
CN118388507A (zh) * 2022-04-08 2024-07-26 上海皓元医药股份有限公司 一种卢比替定的晶型及其制备方法
CN115677728A (zh) * 2022-11-02 2023-02-03 成都科岭源医药技术有限公司 一种海鞘素类化合物中间体的制备方法
CN116332932B (zh) * 2023-02-17 2024-07-09 四川大学 Ecteinascidin 743及类似生物碱的几种高级中间体的制备方法
WO2024186263A1 (en) 2023-03-07 2024-09-12 Axcynsis Therapeutics Pte. Ltd. Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
DE3774435D1 (de) 1986-06-09 1991-12-12 Univ Pennsylvania Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
GB9918178D0 (en) * 2000-05-15 1999-10-06 Pharma Mar Sa Synthetic methods
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
JP5102925B2 (ja) 2000-02-11 2012-12-19 プレジデント アンド フェローズ オブ ハーバード カリッジ エクテインアシジン及びフタルアシジンのための中間体の合成方法
US6815544B2 (en) 2000-02-11 2004-11-09 President And Fellows Of Harvard College Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
US6569859B1 (en) 2000-02-22 2003-05-27 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
US7919493B2 (en) 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
PT1280809E (pt) 2000-04-12 2005-11-30 Pharma Mar Sa Derivados antitumorais de ecteinascidina
US7420051B2 (en) 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
JP4208469B2 (ja) 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
JP4399175B2 (ja) * 2003-01-29 2010-01-13 陽徳 久保 新規レニエラマイシン系化合物の取得方法
JP4170799B2 (ja) * 2003-03-10 2008-10-22 独立行政法人科学技術振興機構 抗腫瘍活性物質エクチナサイジン７４３の改良合成法
EP1792904A1 (en) 2005-10-20 2007-06-06 Centre National de la Recherche Scientifique (CNRS) Intermediate and process of preparation of ecteinascidin using such intermediate
WO2007087220A2 (en) 2006-01-25 2007-08-02 The Trustees Of Columbia University In The City Of New York The total synthesis of ecteinascidin 743 and derivatives thereof

Also Published As

Publication number Publication date
CA2800097A1 (en) 2011-12-01
ES2534331T3 (es) 2015-04-21
US20130066067A1 (en) 2013-03-14
EP2576569B1 (en) 2015-01-14
IL223220A (en) 2016-03-31
CN103038240A (zh) 2013-04-10
AU2011257277B2 (en) 2016-02-25
AU2011257277A1 (en) 2012-12-06
IL223220A0 (en) 2013-02-03
CN107033164A (zh) 2017-08-11
CA2800097C (en) 2019-01-08
US9428524B2 (en) 2016-08-30
JP6037337B2 (ja) 2016-12-07
JP2013526599A (ja) 2013-06-24
EP2576569A1 (en) 2013-04-10
WO2011147828A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
HK1184440A1 (zh) 製備海鞘素化合物及中間體的合成方法
HK1207382A1 (zh) 合成富馬酸乙酯的方法及其作為中間體的用途
IL246265B (en) A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
HK1205105A1 (zh) 製備化合物的方法及其合成中間體
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
ZA201302670B (en) Process for the manufacture of degarelix and its intermediates
LT2632934T (lt) Degarelikso ir jo tarpinių darinių gamybos būdas
SI2609075T1 (sl) Postopek za pripravo intermediatov za izdelavo NEP inhibitorjev
IL226677A (en) Beta-amyloid production compounds
HK1194733A1 (zh) 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體
SI2576556T1 (sl) Postopek za sintezo karbonukleozida in intermediatov za uporabo v tem postopku
EP2643308A4 (en) PROCESS FOR THE PREPARATION OF TAUROLIDINE AND ITS INTERMEDIATE PRODUCTS
HK1174031A1 (zh) 噁唑化合物的合成中間體及其製備方法
IL231292A0 (en) Production of alkaloids without the isolation of intermediates
SI2739610T1 (sl) Postopek za izdelavo ivabradina in intermediatov za sintezo le-tega
GB201021522D0 (en) Novel compounds and methods for their production
PL391539A1 (pl) Sposób wytwarzania tworzyw akrylowo-formaldehydowo-mocznikowych